A Pilot Phase II Study of Digoxin in Patients With Recurrent Prostate Cancer as Evident by a Rising PSA.

Journal of Clinical Oncology - United States
doi 10.1200/jco.2013.31.15_suppl.5061
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

A Pilot Study Evaluating Serum Pro-Prostate-Specific Antigen in Patients With Rising PSA Following Radical Prostatectomy

Oncology Letters
Cancer ResearchOncology
2012English

A Multicenter Phase I/Ii Study of Enzalutamide in Japanese Patients With Castration-Resistant Prostate Cancer

International Journal of Clinical Oncology
MedicineSurgeryOncologyHematology
2016English

A 1,408 Km Bicycle Tour With Prostate Cancer Patients—results of a Pilot Study

European Review of Aging and Physical Activity
GerontologyGeriatrics
2013English

Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial

Urology
Urology
2010English

A Pilot Phase II Study of Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Resectable Colon Cancer

Chinese Journal of Cancer Research
Cancer ResearchOncology
2016English

Prognostic Significance of Rising Prostate-Specific Antigen (PSA) Levels Following Radiation Therapy for Localized Prostate Cancer—Comparison Between PSA Bounce Versus PSA Recurrence

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer

Integrative Cancer Therapies
OncologyAlternative MedicineComplementary
2018English

A Phase II Randomized Pilot Study Comparing High-Dose Rate Brachytherapy and Low-Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

Phase II Study on the Combination of Irinotecan Plus Cisplatin as a Second-Line Therapy in Patients With Advanced or Recurrent Gastric Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy